UNCY as of Nov 3 · 18:21 ET
UNCYNasdaqPharmaceutical Preparations

Unicycive Therapeutics, Inc. · Brief

Next report

8 days

Nov 11 · before openest.Q3 FY26

Expected move

No implied move.

Implied vs realized

1 reportHistory
—≥ implied
Q2 FY26±12.0%▲+7.80%×0.65
quarterimplied−15%0+15%realized×
Q2 FY26±12.0%▲+7.80%×0.65
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 11 report · est.

Bull2 of 3

79managers reporting a position in the latest quarterly filings13F · Jun 30 '26
16managers whose positions together make up four fifths of the reported value13F · Jun 30 '26

Bear1

3 of 21of the largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26
AI captions · Sep 28 '26once per report · top 2 per case

Linked exposure

UNCY report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 28impliedImplied move: ±34.5% into Nov 11 earnings (Oct 28 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.